Written by Riya Joseph
Dwelling to 52 species of venomous snakes, India studies over 50,000 deaths yearly owing to snakebite envenomation. Collectively referred to as the ‘Huge 4’, frequent krait (Bungarus caeruleus), Russell’s viper (Daboia russelii), Indian saw-scaled viper (Echis carinatus), and Indian Cobra (Naja naja) are the 4 species accountable for almost all of those casualties.
Presently, a polyvalent anti-venom technique is employed to deal with snakebite victims whereby the venoms of those 4 species are combined and injected into the host to boost antibodies. As this may increasingly trigger issues and side-effects, now, a Thiruvananthapuram-based startup Indriyam Biologics Pvt. Ltd has provide you with an ingenious machine that performs species-specific prognosis of snake envenomation.
“The polyvalent technique fails to establish the species of the snake and particularly counter its venom. This technique is counterproductive because the affected person is uncovered to 3 different anti-venom that are wholly pointless, resulting in issues and unwanted effects,” mentioned Dr Dileepkumar, co-founder of Indriyam Biologics.
Indriyam Biologics, recognised by the Division of Scientific and Industrial Analysis (DSIR) and Startup India, intends to resolve this challenge by their new monovalent snake-venom detection biosensor machine which finds out if a snakebite is venomous or non-venomous by analysing a drop of the sufferer’s blood. Additionally it is able to distinguishing the species of the snake and the amount of venom circulating within the affected person’s physique.
The expertise was developed by Dr Dileepkumar with the co-founder of Indriyam Biologics Dr Anaswara Krishnan S and a number of different certified palms in snake envenomation therapy like Dr Oommen V Oommen, Dr Sudhakaran (College of Kerala), Dr Joseph Ok Joseph (Little Flower Hospital, Angamaly), Dr Vipin Nair, Dr Sudarslal S, and Dr Jaideep C Menon (Amrita College).
Along with the diagnostic machine, the Kerala startup can be growing snakebite kits following the lateral circulate assay mannequin for fast detection of snakebites.
Dr Dileepkumar and Dr Anaswara Krishan based Indriyam Biologics in 2017 to revolutionise snakebite diagnostics and therapeutics by enhancing scientific data and incorporating novel technological protocols to make merchandise higher, safer and extra economical.
(Riya Joseph is an intern with indianexpress.com primarily based in Thiruvananthapuram)